Skip to main content

IntegenX Names First Partner for RapidHit 200 Early Access Program

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – IntegenX today announced the launch of its Early Access Program for the RapidHit 200 Human Identification System and the signing of Key Forensic Sciences as the first international partner of the program.

The new program provides IntegenX's partners with advanced product access and training, and partners will receive pre-production prototypes of the RapidHit 200 instrument, disposable reagent cartridges, and application priority in the US and abroad, the Pleasanton, Calif.-based company said.

As the first partner in the Early Access Program, Key Forensic Sciences will be able to optimize and use the RapidHit 200 instrument for commercial forensic services in the UK, where it is based. Objectives of the partnership include validation of the system and introduction of fast human ID services to police forces in the UK and Wales.

RapidHit 200 automates and accelerates production of standardized DNA profiles from mouth swabs and other human tissue samples.

Terms of the deal were not disclosed.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.